Reaction

Which drugs are most reported with Hair growth abnormal?

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 6,834 reports · 150 co-occurring drugs

As of the last recalculation, Hair Growth Abnormal appears in 6,834 FAERS reports alongside 150 co-occurring drug terms. The strongest observed disproportionality signal is MINOXIDIL (PRR 49.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Minoxidil	656	49.1	49.8
Bimatoprost	188	20.4	20.5
Biotin	125	12.4	12.5
Minoxidil Foam 5% (Womens)	120	11.3	11.3
Vismodegib	29	10.0	10.0
Docetaxel Anhydrous	201	9.3	9.4
Docetaxel	201	9.3	9.4
Voclosporin	26	9.1	9.2
Niraparib	65	9.0	9.0
Anastrozole	97	8.1	8.2
Testosterone	62	8.1	8.2
Gefitinib	21	7.1	7.1
Erlotinib	22	6.9	6.9
Panitumumab	31	6.1	6.1
Erlotinib Hydrochloride	24	5.9	5.9
Anastrozole Tablets	40	5.7	5.7
Testosterone Cypionate	14	4.8	4.8
Rucaparib	13	4.5	4.5
Progesterone	31	4.1	4.1
Estradiol Gel 0.1%	60	4.1	4.1
Estradiol Transdermal	60	4.1	4.1
Felodipine Extended-Release Tablets	15	4.0	4.0
Felodipine	15	4.0	4.0
Goserelin	17	3.9	3.9
Diphenoxylate Hydrochloride And Atropine Sulfate	17	3.8	3.8
Finasteride	74	3.8	3.8
Tretinoin	10	3.8	3.8
Dutasteride	10	3.7	3.8
Thyroid, Porcine	13	3.7	3.7
Ado-Trastuzumab Emtansine	10	3.6	3.6
Estradiol	99	3.5	3.5
Avapritinib	14	3.5	3.5
Tofacitinib	198	3.3	3.3
Cetuximab	34	3.3	3.3
Ketoconazole Foam	16	3.3	3.3
Ketoconazole Cream, 2%	16	3.3	3.3
Carboxymethylcellulose Sodium	10	3.2	3.2
Abemaciclib	21	3.2	3.2
Ketoconazole	18	3.2	3.2
Travoprost	9	3.2	3.2
Baricitinib	10	3.2	3.2
Calcium	151	3.1	3.1
Letrozole	63	3.1	3.1
Palbociclib	96	3.1	3.1
Fam-Trastuzumab Deruxtecan-Nxki	10	3.0	3.0
Hyoscyamine Sulfate	9	3.0	3.0
Amlodipine Besylate And Benazepril Hydrochloride	9	3.0	3.0
Bleomycin Sulfate	10	3.0	3.0
Ribociclib	30	2.9	2.9
Exemestane	20	2.8	2.9
Teriflunomide	42	2.8	2.8
Bicalutamide	14	2.8	2.8
Sucralfate Oral	13	2.8	2.8
Sucralfate Oral Suspension	13	2.8	2.8
Fulvestrant	30	2.8	2.8
Encorafenib	9	2.8	2.8
Teriparatide	100	2.7	2.7
Fish Oil	80	2.7	2.7
Quinapril Hydrochloride	7	2.7	2.7
Abaloparatide	26	2.7	2.7
Vitamin C	80	2.7	2.7
Letrozole Tablets	42	2.7	2.7
Triamcinolone Acetonide	27	2.7	2.7
Clobetasol Propionate Ointment Usp, 0.05%	9	2.7	2.7
Clobetasol Propionate	9	2.7	2.7
Budesonide	51	2.6	2.7
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide	26	2.6	2.6
Leuprolide Acetate	66	2.6	2.6
Zinc	21	2.6	2.6
Mesna Injection	7	2.6	2.6
Zinc Chloride	21	2.6	2.6
Zinc Gluconate	22	2.6	2.6
Tofacitinib Citrate	11	2.6	2.6
Mesna	7	2.5	2.5
Liothyronine Sodium	7	2.4	2.5
Ergocalciferol	301	2.4	2.4
Latanoprost	40	2.4	2.4
Indapamide	14	2.4	2.4
Losartan Potassium And Hydrochlorothiazide	9	2.4	2.4
Cyclosporine	85	2.3	2.3
Guanfacine	6	2.3	2.3
Loperamide Hydrochloride	34	2.3	2.3
Prochlorperazine Maleate	7	2.3	2.3
Etonogestrel	36	2.3	2.3
Levothyroxine Sodium	228	2.3	2.3
Triamcinolone Acetonide Ointment Usp, 0.05%	17	2.2	2.2
Lovastatin	18	2.1	2.1
Estrogens, Conjugated	41	2.1	2.1
Niacin	8	2.1	2.1
Alpelisib	6	2.1	2.1
Conjugated Estrogens	40	2.1	2.1
Loperamide Hydrochloride Oral	7	2.1	2.1
Raloxifene Hydrochloride	10	2.1	2.1
Hydroxyzine Hydrochloride	9	2.1	2.1
Hydroxyzine Hydrochloride Oral	9	2.1	2.1
Pertuzumab	18	2.0	2.0
Eltrombopag Olamine	15	2.0	2.0
Ziprasidone Mesylate	9	1.9	1.9
Rimegepant Sulfate	8	1.9	1.9
Medroxyprogesterone Acetate	31	1.9	1.9
Levonorgestrel	118	1.8	1.8
Losartan	101	1.8	1.8
Prochlorperazine	16	1.8	1.8
Lisdexamfetamine Dimesylate	19	1.8	1.8
Olaparib	12	1.7	1.7
Ziprasidone	10	1.7	1.7
Osimertinib	18	1.7	1.7
Trastuzumab	38	1.7	1.7
Sumatriptan	21	1.7	1.7
Conjugated Estrogens And Medroxyprogesterone Acetate	13	1.7	1.7
Somatropin	40	1.7	1.7
Levocetirizine Dihydrochloride	13	1.6	1.6
Multivitamin	26	1.6	1.6
Apalutamide	6	1.6	1.6
Lanreotide Acetate	4	1.6	1.6
Relugolix	12	1.6	1.6
Nilotinib	15	1.6	1.6
Dorzolamide Hydrochloride And Timolol Maleate	4	1.5	1.5
Vemurafenib	6	1.5	1.5
Asfotase Alfa	5	1.5	1.5
Armodafinil	10	1.4	1.4
Brinzolamide	4	1.4	1.4
Sunitinib Malate	18	1.4	1.4
Regorafenib	5	1.3	1.3
Crisaborole	4	1.3	1.3
Ibrutinib	33	1.2	1.2
Ruxolitinib	29	1.2	1.2
Lapatinib	6	1.2	1.2
Loratadine And Pseudoephedrine Sulfate	3	1.1	1.1
Naproxen Sodium Tablet	20	1.1	1.1
Isotretinoin	18	1.1	1.1
Paliperidone Palmitate	11	1.0	1.0
Bosutinib	3	1.0	1.0
Elexacaftor, Tezacaftor, And Ivacaftor	4	1.0	1.0
Enzalutamide	18	0.9	0.9
Peginterferon Alfa-2A	16	0.9	0.9
Dalfampridine	21	0.9	0.9
Tafamidis	3	0.8	0.8
Dupilumab	118	0.7	0.7
Ixekizumab	9	0.7	0.7
Alirocumab	6	0.7	0.7
Dulaglutide	20	0.7	0.7
Lenalidomide	93	0.7	0.7
Erenumab-Aooe	11	0.6	0.6
Pomalidomide	20	0.6	0.6
Valbenazine	4	0.5	0.5
Cinacalcet Hydrochloride	7	0.5	0.5
Apremilast	20	0.4	0.4
Copper	5	0.4	0.4
Adapalene	10	0.2	0.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.